Abstract
No public abstract is available from the verified source records.
Fengying Yin, Qianqian Dang, Xiaoxia Wu, Saining Wang
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics
10.1016/j.gendis.2022.02.007 · 2022
Nanoparticle-mediated immunogenic cell death enables and potentiates cancer immunotherapy
10.1002/anie.201804882 · 2018
Current status of nanoparticle-mediated immunogenic cell death in cancer immunotherapy
10.1016/j.intimp.2024.113085 · 2024
Short-term high-dose gemcitabine induces PERK-mediated immunogenic cell death and potentiates antitumor immunity in bladder cancer
10.1016/j.intimp.2025.115057 · 2025
Hybrid cell membrane-functionalized Nanoagents synergistically enhance Cuproptosis-mediated immunotherapy by dual modulation of glycolytic metabolism and tumor microenvironments
10.1021/acsnano.5c10671 · 2025
Amplifying “eat me signal” by immunogenic cell death for potentiating cancer immunotherapy
10.1111/imr.13251 · 2023
Eliciting immunogenic cell death via a unitized Nanoinducer
10.1021/acs.nanolett.0c00713 · 2020
Self-assembled Immunostimulatory tetrahedral framework nucleic acid vehicles for tumor chemo-immunotherapy
10.1021/acsami.2c09462 · 2022
The application of ICG-based photodynamic therapy combined with nanotechnology in tumor treatment
10.1039/d5ra08557h · 2026
Immunogenic cell death inducers for enhanced cancer immunotherapy
10.1039/d1cc04604g · 2021
Molecular basis of graphene-induced oxidative stress and mitochondrial signaling in target cells: consequences for therapeutic window and design of redox-responsive payloads
10.1016/j.tmed.2026.100008 · 2026
A type I/II photosensitizer with lysosome-targeting capabilities induces immunogenic cell death in Cancer cells to enhance tumor immunotherapy
10.1021/acsnano.5c14676 · 2026
Oxidative stress amplifiers as immunogenic cell death nanoinducers disrupting mitochondrial redox homeostasis for cancer immunotherapy
2022
Engineering a therapy-induced “immunogenic cancer cell death” amplifier to boost systemic tumor elimination
2020
Non-mitotic effect of albendazole triggers apoptosis of human leukemia cells via SIRT3/ROS/p38 MAPK/TTP axis-mediated TNF-α upregulation
10.1016/j.bcp.2018.11.003 · 2019
Albendazole as a promising molecule for tumor control
10.1016/j.redox.2016.09.013 · 2016
Albendazole: a review of anthelmintic efficacy and safety in humans
10.1017/s0031182000007290 · 2000
Nanoformulations of albendazole as effective anticancer and antiparasite agents
10.2217/nnm-2017-0102 · 2017
Therapeutic efficacy of nanocompounds in the treatment of cystic and alveolar echinococcoses: challenges and future prospects
10.1007/s00436-019-06416-5 · 2019
Optimized synthesis and crystalline stability of γ-cyclodextrin metal-organic frameworks for drug adsorption
10.1016/j.ijpharm.2016.09.029 · 2016
A γ-cyclodextrin-based metal–organic framework (γ-CD-MOF): a review of recent advances for drug delivery application
2021
Cyclodextrin-based metal–organic framework nanoparticles as superior carriers for curcumin: study of encapsulation mechanism, solubility, release kinetics, and antioxidative stability
10.1016/j.foodchem.2022.132605 · 2022
Composite CD-MOF nanocrystals-containing microspheres for sustained drug delivery
10.1039/c6nr07593b · 2017
Preparation of two metal organic frameworks (K-β-CD-MOFs and Cs-β-CD-MOFs) and the adsorption research of myricetin
10.1016/j.poly.2020.114983 · 2021
Microwave-assisted rapid synthesis of γ-cyclodextrin metal–organic frameworks for size control and efficient drug loading
10.1021/acs.cgd.6b01658 · 2017
Resveratrol-loaded core-shell nanostructured delivery systems: cyclodextrin-based metal-organic nanocapsules prepared by ionic gelation
10.1016/j.foodchem.2020.126328 · 2020
Enhanced stability and solidification of volatile eugenol by Cyclodextrin-metal organic framework for nasal powder delivery
10.1208/s12249-024-02839-1 · 2024
Encapsulation of menthol into cyclodextrin metal-organic frameworks: preparation, structure characterization and evaluation of complexing capacity
2020
Boosting antitumor immunity via a tumor microenvironment-responsive transformable trifecta nanovaccine
2024
Thermo-responsive hydrogel loading hypericin induces pro-inflammatory response against Trichinella spiralis infection via toll-like receptor 3 activation
2024
Dihydroartemisinin remodels tumor micro-environment and improves cancer immunotherapy through inhibiting cyclin-dependent kinases
10.1016/j.intimp.2024.112637 · 2024
Functionalized Trichinella spiralis anti-tumor protein with polydopamine for hepatocellular carcinoma phototherapy and immunotherapy
10.1016/j.bioorg.2025.108796 · 2025
Boosting the synergism between cancer ferroptosis and immunotherapy via targeted stimuli-responsive liposomes
2023
Nanocarrier-induced inflammation: mechanisms, immunometabolic impacts and strategies for safer design
10.1016/j.tmed.2026.100002 · 2026
Bacterial foreignization Nanosystem elicits multi-phenotypic T cells for antitumor immunity
10.1002/advs.202504155 · 2025
Tetrahydrobenzimidazole TMQ0153 triggers apoptosis, autophagy and necroptosis crosstalk in chronic myeloid leukemia
10.1038/s41419-020-2304-8 · 2020
Selective sensing of DNA and live/dead cells and histological imaging based on a perylene derivative
10.1039/d1cc00145k · 2021
Repurposing chemotherapeutics in a hyaluronic acid-conjugate combination treatment approach for the local immunomodulation of the glioblastoma microenvironment
10.1016/j.ijpharm.2025.125612 · 2025
Pharmacokinetics of weekly low dose doxorubicin
10.1016/0277-5379(89)90007-2 · 1989
Optimizing dose selection for doxorubicin-induced cardiotoxicity in mice: a comprehensive analysis of single and multiple-dose regimens
10.1016/j.ejphar.2025.177883 · 2025
The promise and potential of liver organoids: development, classification and application
10.1016/j.tmed.2026.100003 · doi-reference
The application development of nanoparticle-based drug delivery systems in combating drug resistance of lung cancer
10.1016/j.aej.2025.12.002 · doi-reference
CD69: from activation marker to metabolic gatekeeper
10.1002/eji.201646837 · doi-reference
Dendritic cells and the control of immunity
10.1038/32588 · doi-reference
Hollow aluminum hydroxide modified silica nanoadjuvants with amplified immunotherapy effects through immunogenic cell death induction and antigen release
10.1002/smll.202202462 · doi-reference
Albumin nanostructure assisted ABZ anti-parasite immune therapy for T. spiralis muscle infection
10.1016/j.bioadv.2023.213434 · doi-reference
Spray drying encapsulation of CD-MOF nanocrystals into Eudragit® RS microspheres for sustained drug delivery
10.1016/j.jddst.2021.102593 · doi-reference
Determination of subcutaneous tumor size in athymic (nude) mice
10.1007/bf00300234 · doi-reference